Establishment Labs Holdings Inc. (ESTA) stock
Close on Nov 13, 2026Market cap $2.11BP/E –Yield –
Establishment Labs Holdings Inc. grew revenue 38.3% to $264.03M over the twelve months to Sep 30, 2026. Free cash flow was -$21.60M. At the latest close the market valued the company at $2.11B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $2.11B
- P/E ratio
- –
- Price to sales
- 7.99
- Price to book
- 135.21
- Dividend yield
- –
- Free cash flow yield
- -1.02%
Fundamentals
- Revenue
- $264.03M
- Net income
- -$38.45M
- EPS, diluted
- -$1.28
- Free cash flow
- -$21.60M
- Book value per share
- $0.51
- Diluted shares
- 30M
Trading
- Next earnings
- Feb 23, 2027 (estimated, before the open)
- Previous close
- $68.62
- Open
- $68.98
- Day's range
- $67.56 – $71.58
- Volume
- 367,354
- Average volume (20 days)
- 517,586
- Beta (5 years)
- 1.18
- 52-week range
- $53.16 – $97.59
- RSI (14 days)
- 58.6
- Volatility (1 year)
- 49.8%
- Relative volume
- 0.83×
- WACC
- 10.7%
Market cap history
Month-end market cap since 2018, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ESTA | S&P 500 | Difference | ESTA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +21.0% | -3.0% | +24.1 pts | ||
| 3 months | -6.4% | -2.8% | −3.6 pts | ||
| Year to date | -2.9% | +11.5% | −14.4 pts | ||
| 1 year | +9.3% | +13.5% | −4.2 pts | ||
| 3 years | +220.9% | +77.7% | +143.2 pts | +47.5% | +21.1% |
| 5 years | +5.9% | +72.6% | −66.7 pts | +1.1% | +11.5% |
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Establishment Labs filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Results
- Update
About Establishment Labs
Orthopedic, Prosthetic & Surgical Appliances & Supplies
The company is a global medical technology enterprise dedicated to patient safety and aesthetic outcomes within the breast aesthetics and reconstruction sectors. Its primary product line comprises Motiva Implants, silicone gel-filled breast implants that feature proprietary shell, barrier, and radio-frequency identification technologies. The portfolio includes five distinct families of Motiva Implants, the Flora Tissue Expander, and minimally invasive procedural technologies such as Preservé and Mia Femtech. The business distributes its offerings directly to physicians, hospitals, and clinics, as well as through specialized third-party medical device distributors.
Company profile, executives and historyEstablishment Labs stock: common questions
What is Establishment Labs's stock price?
ESTA closed at $70.75 on Nov 13, 2026, up 3.10% on the day. Over the past 52 weeks it traded between $53.16 and $97.59.
What is Establishment Labs's market cap?
Establishment Labs was worth $2.11B at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is ESTA's P/E ratio?
Establishment Labs lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.28), so it has no meaningful P/E ratio.
How much revenue does Establishment Labs make?
Establishment Labs reported revenue of $264.03M for the twelve months to Sep 30, 2026, up 38.3% from a year earlier.
Does Establishment Labs pay a dividend?
No. Establishment Labs has not paid a cash dividend over the last twelve months.
When does Establishment Labs report earnings next?
Establishment Labs is expected to report Q4 FY2026 results on Feb 23, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has ESTA stock performed over the past year?
Including dividends, ESTA returned +9.3% over the past year, against +13.5% for the S&P 500.
How many ESTA shares are sold short?
4M shares were sold short at the latest FINRA report, 14.55% of the float, or 6.7 days of average trading volume.
Who are Establishment Labs's competitors?
Companies most similar to Establishment Labs by business, industry and size include INMD, SMTI, SIBN, INGN, AXGN.
See a number that looks wrong?